Physicians should carefully weigh the potential risks and benefits of its use on a long term basis. Patients should be instructed to watch for signs of serious GI adverse events and they should be monitored more closely than if they were on another NSAID.
Use in Children: Safety and efficacy in children have not been established. Therefore, Ketorolac trometamol (Marolac) is contraindicated for use in children under 16 years of age.
Other Services
Country
Account